Literature DB >> 10029412

Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells.

M Krasilnikov1, V Adler, S Y Fuchs, Z Dong, A Haimovitz-Friedman, M Herlyn, Z Ronai.   

Abstract

The activity of phosphatidylinositol 3-kinase (PI3K), a key component of multiple signal transduction pathways, was investigated in early- and late-stage melanoma cells that have varying degrees of radiation resistance. Analysis of PI3K biproducts (PI-3,4-P2 and PI-3,4,5-triphosphate) revealed a direct correlation between radiation resistance and levels of PI3K activity. Treating melanoma cells with wortmanin or LY294002, two different PI3K inhibitors, decreased PI3K activity and caused a dose-dependent decrease in resistance to ultraviolet radiation. Lower resistance to radiation elicited by LY294002 coincided with increased apoptosis. To further establish the role of PI3K in radiation resistance, we transfected early-stage melanoma cells with the cDNA of p85, the regulatory subunit of PI3K. Clones that constitutively overexpressed p85 exhibited a higher degree of PI-3,4-P2 synthesis and a corresponding increase in their resistance to ultraviolet radiation. The results of this study point to the role of PI3K and its biproducts in radiation resistance of human melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10029412     DOI: 10.1002/(sici)1098-2744(199901)24:1<64::aid-mc9>3.0.co;2-2

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  16 in total

1.  Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Wei-Peng Wang; Xue-Guang Zhang
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

Review 2.  Molecular biology in prostate cancer.

Authors:  José Ramón Cansino Alcaide; Luis Martínez-Piñeiro
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

3.  Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls cell survival after ionizing radiation.

Authors:  Seon Young Nam; Hyung Ho Seo; Hyung Sun Park; Sungkwan An; Ji-Young Kim; Kwang Hee Yang; Cha Soon Kim; Meeseon Jeong; Young-Woo Jin
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

4.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

5.  4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells.

Authors:  Florastina Payton; Rumu Bose; William L Alworth; Addanki P Kumar; Rita Ghosh
Journal:  Biochem Pharmacol       Date:  2011-03-23       Impact factor: 5.858

6.  Vertical targeting of the phosphatidylinositol-3 kinase pathway as a strategy for treating melanoma.

Authors:  Saadia A Aziz; Lucia B Jilaveanu; Christopher Zito; Robert L Camp; David L Rimm; Patricia Conrad; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2010-12-15       Impact factor: 12.531

Review 7.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

8.  Phosphatidylinositol-3-kinase as a therapeutic target in melanoma.

Authors:  Saadia A Aziz; Michael Davies; Elah Pick; Christopher Zito; Lucia Jilaveanu; Robert L Camp; David L Rimm; Yuval Kluger; Harriet M Kluger
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

9.  Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.

Authors:  W Li; Y Xie; R W-Y Sun; Q Liu; J Young; W-Y Yu; C-M Che; P K Tam; Y Ren
Journal:  Br J Cancer       Date:  2009-06-23       Impact factor: 7.640

Review 10.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.